Replies to post #26340 on Marker Therapeutics Inc (MRKR)

[microcapbiotech]

PHANTOMLORD - if you get some time,
Can you give your opinions on 2 things?

One is the question by another in post 26340 concerning the word used today by Marker - "pivotal".
I kind of thought the same thing when I read it.
Do you think there is an additional hope there?

The other is this question (or statement) that the amount of MRKR shares available to be shorted (being very low) (and I've called the 4 major brokerages to verify a number of times) is potentially good news for the share price as there can't be much more shares shorted?

And the fact that 3 1/2 million of those shorts were below $7 (being shorted after Jan 1st.)

You're the voice of calm and reason so I'd love to hear your reasoning concerning these matters.

THANK YOU

[hanscott]

rwwest, from:

http://www.virginia.edu/vpr/irb/HSR_docs/CLINICAL_TRIALS_Phases.pdf

"Phase IIb: Well controlled trials to evaluate efficacy ( and safety) in patients with the disease or condition to be treated, diagnosed, or prevented. These clinical trials usually represent the most rigorous demonstration of a medicine's efficacy.
Sometimes referred to as pivotal trials.


Phase IIIa: Trials conducted after efficacy of the medicine is demonstrated, but prior to regulatory submission of a New Drug Application (NDA) or other dossier. . . "